Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 108679
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.108679
Table 1 Clinical data of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Hepatocellular carcinoma (n = 40)
Intrahepatic cholangiocarcinoma (n = 18)
t/χ²
P value
Age59.95 ± 9.3261.72 ± 8.17-0.6940.490
Sex12.0020.001b
Male358
Female510
Size5.79 ± 3.408.25 ± 2.58-2.8910.005b
Child-Pugh2.1450.143
A3815
B23
History of hepatitis9.9080.007b
Hepatitis B256
Hepatitis C50
Without512
Laboratory index
Alpha-fetoprotein32/40 5/1814.6570.000b
Carbohydrate antigen 19-97/4011/1811.0310.001b
Carcinoembryonic antigen6/405/181.3190.251
Abnormal prothrombin32/403/1820.8080.000b